(Q65353959)
Statements
A Registry Study to Evaluate the Survival and Long-Term Safety of Subjects Who Previously Received Talimogene Laherparepvec in Amgen or BioVEX-Sponsored Clinical Trials (English)
0 references
27 April 2010
0 references
23 March 2023
0 references
340
0 references
18 year
0 references
99 year
0 references